Trials / Completed
CompletedNCT03824028
Post-Market Clinical Survey of Clareon® IOL AutonoMe™ in Japanese Subjects
Post-Market Clinical Survey of Clareon® IOL With the AutonoMe™ Automated Preloaded Delivery System With Japanese Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 384 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This purpose of this survey study is to collect and describe clinical outcomes for the intraocular lens (IOL) delivery performance of Clareon® IOL AutonoMe™ when used in daily practice.
Detailed description
This study will enroll subjects who underwent prior cataract surgery with phacoemulsification and were implanted with Clareon intraocular lenses (IOLs) using the Clareon® IOL AutonoMe™ automated preloaded delivery system. Subjects will be enrolled post-operatively and followed for one year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Clareon® IOL AutonoMe™ automated preloaded delivery system | Disposable injector preloaded with the Clareon IOL for precise IOL insertion during cataract surgery |
Timeline
- Start date
- 2019-02-10
- Primary completion
- 2020-10-20
- Completion
- 2020-10-20
- First posted
- 2019-01-31
- Last updated
- 2021-03-10
Locations
3 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT03824028. Inclusion in this directory is not an endorsement.